SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 57.58+0.9%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (1036)5/2/2000 5:32:00 PM
From: dalroi   of 52153
 
addition and further parking :-)

In January Pharming was issued a third US patent on transgenic
cattle, which broadly covers the production of recombinant
proteins in the milk of transgenic cattle. Also in January a
patent on nuclear transfer technology was issued to Pharming's
partner Infigen, Inc., with claims covering both the use of
primordial germ line derived cells (PGCs), as well as the use of
somatic cells in Infigen's specific NT and cell culture
procedures. Pharming is exclusively licensed under this patent
for the production of pharmaceutical proteins in milk.
In February, an Opposition Division of the European Patent
Office (EPO) revoked one of Pharming's European patents covering
methods for producing transgenic cattle. This Division's
decision ends only the first round of the opposition procedure
and Pharming can and will appeal with the EPO's higher instance,
the Boards of Appeal. Filing of the appeal will restore
Pharming's patent into force. The European Opposition does not
affect Pharming's US patents on transgenic cattle. Pharming's US
patents not only protect the use of transgenic cattle in the USA
but also protect against import of products from transgenic
cattle produced outside the USA.
At present, Pharming's IP portfolio comprises 30 patents
worldwide
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News